PFIZER INC Payments to Acquire Short-term Investments
PFIZER INC (PFE) reported Payments to Acquire Short-term Investments of $5.11 billion for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-04
- PFIZER INC payments to acquire short-term investments for the quarter ending 2026-06-28 was $2.54B, a 22.01% decline year-over-year.
- PFIZER INC payments to acquire short-term investments for the quarter ending 2026-03-29 was $2.57B, a 9.00% decline year-over-year.
- PFIZER INC payments to acquire short-term investments for the quarter ending 2025-12-31 was $4.05B, a 34.46% decline year-over-year.
- PFIZER INC payments to acquire short-term investments for the quarter ending 2025-09-28 was $4.22B, a 56.23% increase year-over-year.
- PFIZER INC payments to acquire short-term investments for fiscal 2025 was $14.36B, a 41.68% increase from fiscal 2024.
- PFIZER INC payments to acquire short-term investments for fiscal 2024 was $10.13B, a 67.29% decline from fiscal 2023.
- PFIZER INC payments to acquire short-term investments for fiscal 2023 was $30.97B, a 14.87% decline from fiscal 2022.
- PFIZER INC payments to acquire short-term investments for fiscal 2022 was $36.38B, a 5.39% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 9 month as first filed | Payments to Acquire Short-term Investments 12 month | Payments to Acquire Short-term Investments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-28 | $2.54B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.11B 10-Q · filed 2026-08-04 | $9.16B derived: sum of 3 quarters · filed 2026-08-04 | $13.38B derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-29 | $2.57B 10-Q · filed 2026-05-05 | $6.62B derived: sum of 2 quarters · filed 2026-05-05 | $10.84B derived: sum of 3 quarters · filed 2026-05-05 | $14.10B derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $4.05B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.27B derived: sum of 2 quarters · filed 2026-02-26 | $11.53B derived: sum of 3 quarters · filed 2026-08-04 | $14.36B 10-K · filed 2026-02-26 | ||
| 2025-09-28 | $4.22B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.49B derived: sum of 2 quarters · filed 2026-08-04 | $10.31B 10-Q · filed 2025-11-04 | $16.48B derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-29 | $3.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.08B 10-Q · filed 2026-08-04 | $12.26B derived: sum of 3 quarters · filed 2026-08-04 | $14.96B derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-30 | $2.82B 10-Q · filed 2026-05-05 | $9.00B derived: sum of 2 quarters · filed 2026-05-05 | $11.70B derived: sum of 3 quarters · filed 2026-05-05 | $12.16B derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $6.18B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.88B derived: sum of 2 quarters · filed 2026-02-26 | $9.34B derived: sum of 3 quarters · filed 2026-02-26 | $10.13B 10-K · filed 2026-02-26 | ||
| 2024-09-29 | $2.70B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.16B derived: sum of 2 quarters · filed 2025-11-04 | $3.96B 10-Q · filed 2025-11-04 | $4.79B derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $457.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.25B 10-Q · filed 2025-08-05 | $2.09B derived: sum of 3 quarters · filed 2026-02-26 | $11.22B derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $797.00M 10-Q · filed 2025-05-05 | $1.63B derived: sum of 2 quarters · filed 2026-02-26 | $10.77B derived: sum of 3 quarters · filed 2026-02-26 | $25.11B derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $836.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.97B derived: sum of 2 quarters · filed 2026-02-26 | $24.31B derived: sum of 3 quarters · filed 2026-02-26 | $30.97B 10-K · filed 2026-02-26 | ||
| 2023-10-01 | $9.13B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $23.47B derived: sum of 2 quarters · filed 2024-11-04 | $30.14B 10-Q · filed 2024-11-04 | $36.82B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-07-02 | $14.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $21.01B 10-Q · filed 2024-08-05 | $27.69B derived: sum of 3 quarters · filed 2025-02-27 | $38.45B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-04-02 | $6.67B 10-Q · filed 2024-05-08 | $13.35B derived: sum of 2 quarters · filed 2025-02-27 | $24.11B derived: sum of 3 quarters · filed 2025-02-27 | $34.29B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $6.68B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $17.45B derived: sum of 2 quarters · filed 2025-02-27 | $27.63B derived: sum of 3 quarters · filed 2025-02-27 | $36.38B 10-K · filed 2025-02-27 | ||
| 2022-10-02 | $10.76B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $20.94B derived: sum of 2 quarters · filed 2023-11-08 | $29.70B 10-Q · filed 2023-11-08 | $41.88B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-07-03 | $10.18B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $18.94B 10-Q · filed 2023-08-09 | $31.11B derived: sum of 3 quarters · filed 2024-02-22 | $41.41B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-04-03 | $8.76B 10-Q · filed 2023-05-10 | $20.93B derived: sum of 2 quarters · filed 2024-02-22 | $31.23B derived: sum of 3 quarters · filed 2024-02-22 | $41.16B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $12.18B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $22.48B derived: sum of 2 quarters · filed 2024-02-22 | $32.40B derived: sum of 3 quarters · filed 2024-02-22 | $38.46B 10-K · filed 2024-02-22 | ||
| 2021-10-03 | $10.30B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $20.23B derived: sum of 2 quarters · filed 2022-11-09 | $26.28B 10-Q · filed 2022-11-09 | $30.78B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-07-04 | $9.93B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $15.98B 10-Q · filed 2022-08-10 | $20.48B derived: sum of 3 quarters · filed 2023-02-23 | $24.65B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-04-04 | $6.05B 10-Q · filed 2022-05-11 | $10.55B derived: sum of 2 quarters · filed 2023-02-23 | $14.72B derived: sum of 3 quarters · filed 2023-02-23 | $17.31B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $4.50B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.66B derived: sum of 2 quarters · filed 2023-02-23 | $11.25B derived: sum of 3 quarters · filed 2023-02-23 | $13.80B 10-K · filed 2023-02-23 | ||
| 2020-09-27 | $4.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.76B derived: sum of 2 quarters · filed 2021-11-12 | $9.31B 10-Q · filed 2021-11-12 | $11.56B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $2.59B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.14B 10-Q · filed 2021-08-12 | $7.39B derived: sum of 3 quarters · filed 2022-02-24 | $7.91B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $2.55B 10-Q · filed 2021-05-13 | $4.80B derived: sum of 2 quarters · filed 2022-02-24 | $5.32B derived: sum of 3 quarters · filed 2022-02-24 | $7.98B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $2.25B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.77B derived: sum of 2 quarters · filed 2022-02-24 | $5.43B derived: sum of 3 quarters · filed 2022-02-24 | $6.83B 10-K · filed 2022-02-24 | ||
| 2019-09-29 | $520.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.18B derived: sum of 2 quarters · filed 2020-11-05 | $4.58B 10-Q · filed 2020-11-05 | $8.90B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $2.66B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.06B 10-Q · filed 2020-08-06 | $8.38B derived: sum of 3 quarters · filed 2021-02-25 | $12.62B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $1.40B 10-Q · filed 2020-05-07 | $5.71B derived: sum of 2 quarters · filed 2021-02-25 | $9.96B derived: sum of 3 quarters · filed 2021-02-25 | $12.17B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $4.31B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.55B derived: sum of 2 quarters · filed 2021-02-25 | $10.76B derived: sum of 3 quarters · filed 2021-02-25 | $11.68B 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $4.24B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $6.45B derived: sum of 2 quarters · filed 2019-11-07 | $7.36B 10-Q · filed 2019-11-07 | $15.49B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-07-01 | $2.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $3.12B 10-Q · filed 2019-08-08 | $11.25B derived: sum of 3 quarters · filed 2020-02-27 | $15.32B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-04-01 | $913.00M 10-Q · filed 2019-05-09 | $9.04B derived: sum of 2 quarters · filed 2020-02-27 | $13.12B derived: sum of 3 quarters · filed 2020-02-27 | $14.81B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $8.13B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $12.20B derived: sum of 2 quarters · filed 2020-02-27 | $13.89B derived: sum of 3 quarters · filed 2020-02-27 | $14.60B 10-K · filed 2020-02-27 | ||
| 2017-10-01 | $4.08B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $5.77B derived: sum of 2 quarters · filed 2018-11-08 | $6.47B 10-Q · filed 2018-11-08 | $7.26B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-07-02 | $1.69B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.39B 10-Q · filed 2018-08-09 | $3.18B derived: sum of 3 quarters · filed 2019-02-28 | $9.61B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-04-02 | $701.00M 10-Q · filed 2018-05-10 | $1.49B derived: sum of 2 quarters · filed 2019-02-28 | $7.91B derived: sum of 3 quarters · filed 2019-02-28 | $13.17B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $787.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $7.21B derived: sum of 2 quarters · filed 2019-02-28 | $12.47B derived: sum of 3 quarters · filed 2019-02-28 | $15.96B 10-K · filed 2019-02-28 | ||
| 2016-10-02 | $6.43B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $11.68B derived: sum of 2 quarters · filed 2017-11-09 | $15.17B 10-Q · filed 2017-11-09 | $22.68B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $5.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $8.74B 10-Q · filed 2017-08-10 | $16.26B derived: sum of 3 quarters · filed 2018-02-22 | $21.30B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | $3.49B 10-Q · filed 2017-05-11 | $11.00B derived: sum of 2 quarters · filed 2018-02-22 | $16.04B derived: sum of 3 quarters · filed 2018-02-22 | $24.52B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2015-12-31 | $7.51B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $12.55B derived: sum of 2 quarters · filed 2018-02-22 | $21.04B derived: sum of 3 quarters · filed 2018-02-22 | $28.58B 10-K · filed 2018-02-22 | ||
| 2015-09-27 | $5.04B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $13.52B derived: sum of 2 quarters · filed 2016-11-10 | $21.07B 10-Q · filed 2016-11-10 | $35.73B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-28 | $8.48B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $16.03B 10-Q · filed 2016-08-11 | $30.69B derived: sum of 3 quarters · filed 2017-02-23 | $45.90B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-29 | $7.55B 10-Q · filed 2016-05-12 | $22.21B derived: sum of 2 quarters · filed 2017-02-23 | $37.42B derived: sum of 3 quarters · filed 2017-02-23 | $49.78B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $14.66B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $29.87B derived: sum of 2 quarters · filed 2017-02-23 | $42.23B derived: sum of 3 quarters · filed 2017-02-23 | $50.95B 10-K · filed 2017-02-23 | ||
| 2014-09-28 | $15.21B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $27.57B derived: sum of 2 quarters · filed 2015-11-05 | $36.29B 10-Q · filed 2015-11-05 | $45.13B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-29 | $12.36B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $21.08B 10-Q · filed 2015-08-06 | $29.91B derived: sum of 3 quarters · filed 2016-02-29 | $42.18B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-30 | $8.72B 10-Q · filed 2015-05-07 | $17.55B derived: sum of 2 quarters · filed 2016-02-29 | $29.82B derived: sum of 3 quarters · filed 2016-02-29 | $40.74B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $8.83B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $21.10B derived: sum of 2 quarters · filed 2016-02-29 | $32.02B derived: sum of 3 quarters · filed 2016-02-29 | $42.76B 10-K · filed 2016-02-29 | ||
| 2013-09-29 | $12.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $23.18B derived: sum of 2 quarters · filed 2014-11-06 | $33.93B 10-Q · filed 2014-11-06 | $43.36B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $10.92B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $21.66B 10-Q · filed 2014-08-07 | $31.09B derived: sum of 3 quarters · filed 2015-02-27 | $35.29B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $10.74B 10-Q · filed 2014-05-08 | $20.17B derived: sum of 2 quarters · filed 2015-02-27 | $24.36B derived: sum of 3 quarters · filed 2015-02-27 | $28.42B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $9.43B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $13.62B derived: sum of 2 quarters · filed 2015-02-27 | $17.67B derived: sum of 3 quarters · filed 2015-02-27 | $24.02B 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $4.19B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $8.24B derived: sum of 2 quarters · filed 2013-11-08 | $14.59B 10-Q · filed 2013-11-08 | $19.58B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $4.05B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $10.39B 10-Q · filed 2013-08-09 | $15.38B derived: sum of 3 quarters · filed 2014-02-28 | $22.28B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | $6.34B 10-Q · filed 2013-05-10 | $11.33B derived: sum of 2 quarters · filed 2014-02-28 | $18.23B derived: sum of 3 quarters · filed 2014-02-28 | $21.44B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2011-12-31 | $4.99B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $11.89B derived: sum of 2 quarters · filed 2014-02-28 | $15.10B derived: sum of 3 quarters · filed 2014-02-28 | $18.45B 10-K · filed 2014-02-28 | $18.43B 10-K · filed 2012-02-28 | |
| 2011-10-02 | $6.90B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $10.11B derived: sum of 2 quarters · filed 2012-11-09 | $13.46B 10-Q · filed 2012-11-09 | $13.46B 10-Q · filed 2011-11-10 | $19.52B derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-07-03 | $3.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $6.56B 10-Q · filed 2012-08-09 | $12.62B derived: sum of 3 quarters · filed 2013-02-28 | $14.11B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-04-03 | $3.35B 10-Q · filed 2012-05-10 | $9.42B derived: sum of 2 quarters · filed 2013-02-28 | $10.90B derived: sum of 3 quarters · filed 2013-02-28 | $12.26B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2010-12-31 | $6.06B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $7.55B derived: sum of 2 quarters · filed 2013-02-28 | $8.90B derived: sum of 3 quarters · filed 2013-02-28 | $11.08B 10-K · filed 2013-02-28 | $10.93B 10-K · filed 2011-02-28 | |
| 2010-10-03 | $1.49B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $2.84B derived: sum of 2 quarters · filed 2011-11-10 | $5.02B 10-Q · filed 2011-11-10 | -$16.80B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-07-04 | $1.35B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $3.53B 10-Q · filed 2011-08-11 | -$18.29B derived: sum of 3 quarters · filed 2012-02-28 | -$38.00M derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-04-04 | $2.18B 10-Q · filed 2011-05-12 | -$19.64B derived: sum of 2 quarters · filed 2012-02-28 | -$1.39B derived: sum of 3 quarters · filed 2012-02-28 | $19.79B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2009-12-31 | -$21.82B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$3.57B derived: sum of 2 quarters · filed 2012-02-28 | $17.61B derived: sum of 3 quarters · filed 2012-02-28 | $35.33B 10-K · filed 2012-02-28 | ||
| 2009-09-27 | $18.25B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | $39.42B derived: sum of 2 quarters · filed 2010-11-12 | $57.15B 10-Q · filed 2010-11-12 | $70.48B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-28 | $21.18B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $38.90B 10-Q · filed 2010-08-12 | $52.24B derived: sum of 3 quarters · filed 2011-02-28 | $58.50B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-29 | $17.72B 10-Q · filed 2010-05-13 | $31.06B derived: sum of 2 quarters · filed 2011-02-28 | $37.32B derived: sum of 3 quarters · filed 2011-02-28 | |||
| 2008-12-31 | $13.34B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $19.60B derived: sum of 2 quarters · filed 2011-02-28 | $35.70B 10-K · filed 2011-02-28 | |||
| 2008-09-28 | $6.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $22.37B 10-Q · filed 2009-11-05 | ||||
| 2008-06-29 | $16.11B 10-Q · filed 2009-08-06 | |||||
| 2007-12-31 | $25.43B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |